Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation ‐ a comparison in a controlled environment

Constipation is a common condition for which PEG 3350 is an established treatment and prucalopride has recently been approved for this indication.To compare the efficacy, safety and impact on quality of life (QoL) of PEG 3350 plus electrolytes (PEG 3350+E) vs. prucalopride in females with chronic constipation (CC) in whom laxatives have previously failed to provide adequate relief.In this single-centre, randomised, double-blind, double-dummy...